SCHMC

Examination of In vitro and In vivo biocompatibility of alginate-hyaluronic acid microbeads As a promising method in cell delivery for kidney regeneration

Metadata Downloads
Abstract
In this study, alginate (ALG) and alginate-hyaluronic acid (ALG-HA) injectable microbeads, with the purpose of delivering stem cells for tissue engineering, were prepared by a spraying method into a CaCl(2) solution that shows high porosity for the exchange of nutrition and waste. In addition, the size distribution and surface morphology was investigated using optical and scanning electron microscopy, respectively. The chemical structural properties of the ALG-HA microbeads were examined by Fourier transform infrared spectroscopy. The biocompatibility of ALG and ALG-HA microbeads was examined in vitro. Rat bone marrow stem cells were encapsulated in microbeads to investigate cell release, cell viability, proliferation, and secretion of growth factors such as VEGF and PDGF. Growth factors were released for the 21day experimental period. Cells were found to be released from the microbeads after 7days. Furthermore, the in vivo biocompatibility of ALG-HA microbeads was examined using microbeads without cell encapsulation in the kidney capsule, in order to assess the foreign body reaction and inflammatory response, for 14days. The desired in vivo response to ALG-HA microbeads hydrogel makes it an exquisite candidate for subcapsular cell and drug delivery to kidney tissue.
All Author(s)
J. Amirian ; T. T. T. Van ; S. H. Bae ; H. I. Jung ; H. J. Choi ; H. D. Cho ; B. T. Lee
Issued Date
2017
Type
Article
Keyword
ALG-HA microbeadsRBMSCsEncapsulationIn vivo biocompatibilityKidney
ISSN
0141-8130
Citation Title
International Journal of Biological Macromolecules
Citation Volume
105
Citation Number
Pt 1
Citation Start Page
143
Citation End Page
153
Language(ISO)
eng
DOI
10.1016/j.ijbiomac.2017.07.019
URI
http://schca-ir.schmc.ac.kr/handle/2022.oak/3263
공개 및 라이선스
  • 공개 구분공개
파일 목록
  • 관련 파일이 존재하지 않습니다.

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.